Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RAD52 | P43351 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10814703 | 0.99 | KMT2A (0.46) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL10811647 | 0.99 | KMT2A (0.46) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL11236048 | 0.99 | KMT2A (0.46) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL3145074 | 0.99 | KMT2A (0.46) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL692463 | 0.97 | KMT2A (0.40) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL11031867 | 0.96 | KMT2A (0.43) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL10910241 | 0.96 | KMT2A (0.43) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL10912242 | 0.96 | KMT2A (0.43) | KMT2ALMNATSHRNR1I2AHR | |
| SCHEMBL11168811 | 0.93 | TSHR (0.36) | KMT2ALMNATSHR | |
| SCHEMBL9367808 | 0.91 | TSHR (0.36) | KMT2ALMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4225974-A | — | — | None | — | — | JP | disclosed |
| US-8830811-B2 | Resin composition and optical component | MITSUI CHEMICALS, INC. (JP) | 2014-09-09 | — | — | US | disclosed |
| EP-1878769-B1 | RESIN COMPOSITION AND OPTICAL COMPONENT | MITSUI CHEMICALS INC (JP) | 2013-04-17 | — | — | EP | disclosed |
| US-8354529-B2 | Polyamine derivative and polyol derivative | BASF SE (DE) | 2013-01-15 | — | — | US | disclosed |
| EP-2511274-A2 | Polyamine derivative | BASF SE (DE) | 2012-10-17 | — | — | EP | disclosed |
| EP-2484677-A1 | Polyamine derivative | BASF SE (DE) | 2012-08-08 | — | — | EP | disclosed |
| US-20120053270-A1 | POLYAMINE DERIVATIVE AND POLYOL DERIVATIVE | MITA NARUYOSHI (JP) | 2012-03-01 | — | — | US | disclosed |
| US-8076478-B2 | Stabilizer; photostability, heat resistance, ozone resistance, oxidation resistance, electromagnetic resistance | BASF SE (DE) | 2011-12-13 | — | — | US | disclosed |
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20090310471-A1 | Resin composition and optical component | MITSUI CHEMICALS, INC. (JP) | 2009-12-17 | — | — | US | disclosed |
| EP-0107615-A1 | Polyolefins stabilized by bis or tris (polyalkylpiperidinyl-amino) 1,3,5-triazines | CIBA-GEIGY AG (CH) | 1984-05-02 | — | — | EP | disclosed |
| EP-0101411-A2 | Process for the chemical bond between a stabilising compound and a polymer | CIBA-GEIGY AG (CH) | 1984-02-22 | — | — | EP | disclosed |
| EP-0075849-A2 | Triazinyllactames, process for their preparation, their use as stabilisators for synthetic organic polymers and polymers stabilised by them | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-04-06 | — | — | EP | disclosed |
| EP-0002005-B1 | PROCESS FOR BLOCKING END GROUPS OF POLYMERIC POLYALKYLPIPERIDINE DERIVATIVES, THE PRODUCTS WITH BLOCKED END GROUPS THUS OBTAINED AND THEIR USE AS LIGHT STABILISERS FOR SYNTHETIC MATERIALS | CIBA-GEIGY AG (CH) | 1983-01-19 | — | — | EP | disclosed |
| US-4322337-A | PHOTOSTABILITY | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| EP-0042554-A1 | Polytriazinyl amines, process for their preparation, their use as stabilizing agents for synthetic polymers and polymers stabilized with these compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-12-30 | — | — | EP | disclosed |
| EP-0014683-B1 | POLYALKYLPIPERIDINE DERIVATIVES OF S-TRIAZINES, THEIR USE AS STABILIZERS FOR POLYMERS AND POLYMER COMPOSITIONS STABILIZED WITH THESE COMPOUNDS | CIBA-GEIGY AG (CH) | 1981-12-23 | — | — | EP | disclosed |
| US-4288593-A | PHOTOSTABILIZERS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1981-09-08 | — | — | US | disclosed |
| US-4234707-A | Polymeric light stabilizers for plastics | CIBA-GEIGY CORPORATION (US) | 1980-11-18 | — | — | US | disclosed |
| EP-0014683-A1 | Polyalkylpiperidine derivatives of s-triazines, their use as stabilizers for polymers and polymer compositions stabilized with these compounds | CIBA-GEIGY AG (CH) | 1980-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100074083-A1 | RESIN COMPOSITION AND MOLDED PRODUCT OBTAINED BY MOLDING THE RESIN COMPOSITION | SEM1, WDR5, WDR1 | KMT2A 736/4885LMNA 2153/4885TSHR 3969/4885 |
| US-20120053270-A1 | POLYAMINE DERIVATIVE AND POLYOL DERIVATIVE | H1-0, H1-3, NPM1 | KMT2A 1254/4885LMNA 315/4885TSHR 1497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.